News
TEVA
32.18
-2.34%
-0.77
Teva lawsuit over generics of Lilly's Forteo brought back by appeals court
Seeking Alpha · 14h ago
U.S. Appeals Court Revives Teva Pharmaceuticals' Lawsuit Against Eli Lilly Over Alleged Violation Of Settlement Agreement
Benzinga · 18h ago
US appeals court revives Teva lawsuit over Lilly osteoporosis drug
Reuters · 18h ago
Weekly Report: what happened at TEVA last week (0706-0710)?
Weekly Report · 1d ago
Teva (TEVA) Stock Looks Reasonable Even With A 48% Gap
Simply Wall St · 3d ago
Jefferies Keeps Their Buy Rating on Teva Pharmaceutical (TEVA)
TipRanks · 3d ago
Novartis vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?
The Motley Fool · 4d ago
Teva And Polpharma Enter Licensing Agreement For Ocrevus Biosimilar Candidate In Multiple Sclerosis
NASDAQ · 4d ago
Teva, Polpharma ink licensing pact for biosimilar targeting Roche’s Ocrevus
Seeking Alpha · 5d ago
Strength Seen in Supernus (SUPN): Can Its 5.2% Jump Turn into More Strength?
NASDAQ · 5d ago
Teva, Polpharma enter global licensing agreement for Ocrevus biosimilar
TipRanks · 5d ago
Teva And Polpharma Biologics Ink Global Licensing Deal For Ocrevus Biosimilar
NASDAQ · 5d ago
Teva Pharmaceuticals International Granted Exclusive Rights To Commercialize Formulations For Polpharma Biologics’ Proposed Biosimilar To Ocrevus
Benzinga · 5d ago
Teva, Polpharma Biologics announce global licensing agreement
TipRanks · 5d ago
Teva Pharma And Polpharma Biologics Announce Global Licensing Agreement Granting Teva Exclusive Rights To Commercialize Both Formulations Of Polpharma Biologics’ Proposed Biosimilar To Ocrevus, Upon Regulatory Approval
Benzinga · 5d ago
TEVA - TO COMMERCIALIZE OCREVUS BIOSIMILAR IN US, EUROPE, BRAZIL, CANADA, AUSTRALIA, NEW ZEALAND, ISRAEL, TURKEY
Reuters · 5d ago
Teva, Samsung Bioepis enter commercialization agreement for OPUVIZ
TipRanks · 5d ago
Teva Pharmaceutical Industries And Samsung Bioepis Partner To Commercialize OPUVIZ Aflibercept Biosimilar In Canada
Benzinga · 5d ago
TEVA - SAMSUNG BIOEPIS TO REGISTER AND MANUFACTURE OPUVIZ; TEVA CANADA TO COMMERCIALIZE
Reuters · 5d ago
Teva (TEVA) Advances TEV 408 Into Phase 2b For Vitiligo After Early Progress
Simply Wall St · 5d ago
More
Webull provides a variety of real-time TEVA stock news. You can receive the latest news about Teva Pharm through multiple platforms. This information may help you make smarter investment decisions.
About TEVA
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.